Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: Ann Surg Oncol. 2013 Aug 22;20(10):3308–3316. doi: 10.1245/s10434-013-3157-5

TABLE 1.

Studies included in occult primary breast cancer pooled analysis

Study Year Country Institution N = (F/U)
Abe et al.14 2000 Japan Shiga University of Medical Science, Shiga 1 (60 months)
Abe et al.15 2010 Japan Shiga University of Medical Science, Shiga 1 (29 months)
Agarwal et al.16 2000 India Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 1 (5 months)
Capobianco et al.17 2007 Italy University of Sassari 1 (72 months)
Fayanju et al.29 2013 United States Siteman Cancer Center, St. Louis 7 (91 months)a
Ko et al.18 2007 South Korea Samsung Medical Center, Seoul 12 (42 months)a,b
Lanitis et al.19 2009 United Kingdom St. Mary’s Hospital, London 3 (40 months)a
Lloyd et al.20 2001 United Kingdom The Royal Marsden Hospital, Sutton 6 (57 months)a
Matsuoka et al.21 2003 Japan The National Shikoku Cancer Center, Matsuyama City 11 (88 months)a
Medina-Franco et al.22 2002 United States University of Alabama, Birmingham 10 (49 months)a
Misra et al.23 2001 India Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow 4 (13 months)a,c
Piekarski et al.24 2003 Poland Medical University of Lodz 22 (37 months)a
Steunebrink et al.25 2005 The Netherlands Albert Schweitzer Hospital, Dordrecht 1 (42 months)
Tamiolakis et al.26 2008 Greece General Hospital of Chania, Crete 1 (12 months)
Teodossiu et al.27 2009 Italy University Hospital, Bari 1 (48 months)
Varadarajan et al.28 2006 United States Roswell Park Cancer Institute, Buffalo 10 (57 months)d

F/U time to follow-up

a

Mean

b

Follow-up information only available for 2 of 12 patients

c

Follow-up information only available for 3 of 4 patients

d

Median